0001391045-15-000003.txt : 20150504
0001391045-15-000003.hdr.sgml : 20150504
20150504160450
ACCESSION NUMBER: 0001391045-15-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150430
FILED AS OF DATE: 20150504
DATE AS OF CHANGE: 20150504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NephroGenex, Inc.
CENTRAL INDEX KEY: 0001338095
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3200 BEECHLEAF COURT
STREET 2: SUITE 900
CITY: RALEIGH
STATE: NC
ZIP: 27604
BUSINESS PHONE: (609) 986-1780
MAIL ADDRESS:
STREET 1: 3200 BEECHLEAF COURT
STREET 2: SUITE 900
CITY: RALEIGH
STATE: NC
ZIP: 27604
FORMER COMPANY:
FORMER CONFORMED NAME: NephroGenex Inc
DATE OF NAME CHANGE: 20050907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Legault Pierre
CENTRAL INDEX KEY: 0001391045
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36303
FILM NUMBER: 15828436
MAIL ADDRESS:
STREET 1: P.O. BOX 1028
STREET 2: C/O STONE MANAGEMENT LLC
CITY: BERWYNE
STATE: PA
ZIP: 19312
4
1
wf-form4_143076988027516.xml
FORM 4
X0306
4
2015-04-30
0
0001338095
NephroGenex, Inc.
NRX
0001391045
Legault Pierre
C/O NEPHROGENEX, INC.
3200 BEECHLEAF COURT, SUITE 900
RALEIGH
NC
27604
1
1
0
0
Chief Executive Officer
Options to Purchase Common Stock
7.31
2015-04-30
4
A
0
50000
0
A
2016-04-30
2025-04-30
Common Stock
50000.0
50000
D
25% of the shares underlying the options will vest on April 30, 2016 and the remainder of the shares underlying the options will vest on a pro rata monthly basis for a three-year period following April 30, 2016.
/s/ Pierre Legault, as attorney in-fact
2015-05-04